
The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family

The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family

The positive opinion comes with the recommendation that ciclosporin 0.1% be granted marketing authorisation in the European Union

Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204 for the treatment of geographic atrophy

Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal geographic atrophy

The company has secured $170 million (approximately €157 million) in Series B funding

The drug is a biosimilar for aflibercept 2 mg (Eylea)

Apellis will seek re-examination from the CHMP following the opinion

At the 2024 ARVO meeting, Andrew D. Pucker, OD, PhD, presented a paper on measuring meibomian gland morphology

Allen Ho, MD, presented on the 12-month results of an mutation agnostic optogenetic programme at the ARVO 2024 meeting

At this year's ARVO meeting, the Eye Care Network got a glimpse at the future of paediatric myopia control research

Elias Kahan speaks about his ARVO poster, "Contact specular microscopy reliably images the same location of the corneal epithelium"

John Sheppard, MD, MSc, FACs, discusses the unique biochemical traits of perfluorohexyloctane for eye dry disease and meibomian gland dysfunction

Paul Kayne, PhD gave an onsite overview of his poster at the 2024 ARVO meeting

Osamah Saeedi, MD, MS, discusses his poster presentation from the ARVO Imaging in the Eye conference

At the ARVO meeting in Seattle, Washington, the Eye Care Network spoke with Giulia Corradetti, MD about AMD

Paolo Silva, MD, speaks on the effect of diabetic retinopathy lesion location and long-term risk of progression

Barry Kuppermann, MD, PhD, director of the Gavin Herbert Eye Institute at the University of California Irvine, speaks about his ARVO poster presentation

Qinqin Zhang, PhD, presented on a deep learning model for GA segmentation at this year's ARVO meeting

At this year's ARVO meeting, Ash Abbey, MD, presented 36-month data from the GALE study of pegcetacoplan

At this year's ARVO meeting, new data from the BLINK2 study show axial growth rates after discontinuing soft multifocal contact lens wear

The meeting kicks off with symposia and an opening keynote speech from Ed Yong

Josefina Botta, MD, MSc, discusses her real-world experiences with the RayOne EMV toric lens

The technology, which creates a 360-degree, instantaneous capsulotomy, appeared at the Eyecelerator event

At ASCRS, Dr Rom Kandavel discusses iStent outcomes for patients who have undergone laser peripheral iridotomy, trabeculectomy and SLT

At this year's ASCRS meeting, J. Morgan Micheletti, MD, talks about his research and the Young Eye Surgeons (YES) programme

Anat Loewenstein, MD, illuminates the outcomes of using an AI-based fluid quantification for remote retina monitoring and analysis

A reduction in clinical exposure has harmed student confidence, according to a questionnaire administered in the United Kingdom

A look back at some of the biggest stories in 2023, from our US partners at Ophthalmology Times

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Marco A. Zarbin, MD, spoke with Ophthalmology Times about his team's post-hoc analysis of the YOSEMITE and RHINE clinical trials